BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.41% |
| 2 | Financials | 6.99% |
| 3 | Consumer Discretionary | 5.47% |
| 4 | Healthcare | 5.09% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Rapid7
RPD
$874M
| $412K | ﹤0.01% |
9,087
+3,669
| +68% | +$206K |
|
|
IMMU
2202
DELISTED
Immunomedics Inc
IMMU
| $412K | ﹤0.01% |
31,070
+10,610
| +52% | +$156K |
|
2203
Chesapeake Utilities
CPK
$3.26B
| $411K | ﹤0.01% |
4,314
+475
| +12% | +$44.4K |
|
2204
NovaGold Resources
NG
$3.53B
| $410K | ﹤0.01% |
67,610
+37,845
| +127% | +$248K |
|
2205
Belden
BDC
$5.34B
| $410K | ﹤0.01% |
7,689
+627
| +9% | +$31.5K |
|
2206
EXL Service
EXLS
$5.3B
| $410K | ﹤0.01% |
30,595
+6,050
| +25% | +$80.8K |
|
2207
Medpace
MEDP
$16.2B
| $409K | ﹤0.01% |
4,865
+1,812
| +59% | +$137K |
|
2208
LCI Industries
LCII
$2.55B
| $408K | ﹤0.01% |
4,447
-3,525
| -44% | -$313K |
|
2209
Cleveland-Cliffs
CLF
$6.81B
| $408K | ﹤0.01% |
56,504
+12,739
| +29% | +$115K |
|
|
GTLS
2210
DELISTED
Chart Industries
GTLS
| $406K | ﹤0.01% |
6,509
+1,253
| +24% | +$84.9K |
|
2211
Brookfield Renewable
BEP
$10.5B
| $405K | ﹤0.01% |
18,694
| – | – |
|
2212
Kratos Defense & Security Solutions
KTOS
$12.1B
| $404K | ﹤0.01% |
21,728
+3,028
| +16% | +$63.6K |
|
2213
Glaukos
GKOS
$11B
| $404K | ﹤0.01% |
6,458
+1,630
| +34% | +$115K |
|
2214
CareTrust REIT
CTRE
$9.22B
| $403K | ﹤0.01% |
17,145
+4,361
| +34% | +$102K |
|
2215
Halozyme
HALO
$11.2B
| $402K | ﹤0.01% |
25,918
+9,136
| +54% | +$150K |
|
2216
Franklin Electric
FELE
$4.67B
| $402K | ﹤0.01% |
8,406
+1,339
| +19% | +$62K |
|
|
CADE
2217
DELISTED
Cadence Bancorporation
CADE
| $402K | ﹤0.01% |
22,910
+6,668
| +41% | +$114K |
|
2218
Korn Ferry
KFY
$4.3B
| $401K | ﹤0.01% |
10,371
+1,784
| +21% | +$68.9K |
|
|
MNTA
2219
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $401K | ﹤0.01% |
30,920
+17,663
| +133% | +$213K |
|
2220
BHP
BHP
$221B
| $400K | ﹤0.01% |
9,086
+3,833
| +73% | +$179K |
|
2221
Advanced Energy
AEIS
$13.3B
| $400K | ﹤0.01% |
6,970
+1,283
| +23% | +$69.3K |
|
2222
Applied Industrial Technologies
AIT
$13.4B
| $400K | ﹤0.01% |
7,043
+908
| +15% | +$51.1K |
|
|
CHL
2223
DELISTED
China Mobile Limited
CHL
| $400K | ﹤0.01% |
9,650
-58,626
| -86% | -$2.5M |
|
2224
Coherent
COHR
$63.9B
| $399K | ﹤0.01% |
11,330
+1,789
| +19% | +$68.2K |
|
2225
Innospec
IOSP
$2.31B
| $399K | ﹤0.01% |
4,471
+574
| +15% | +$51.5K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.